EPIONE
Natural sensory feedback for phantom limb pain modulation and therapy
| Coordinatore | AALBORG UNIVERSITET
Organization address
address: FREDRIK BAJERS VEJ 5 contact info |
| Nazionalità Coordinatore | Denmark [DK] |
| Totale costo | 8˙029˙601 € |
| EC contributo | 5˙982˙840 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2013-INNOVATION-1 |
| Funding Scheme | CP-FP |
| Anno di inizio | 2013 |
| Periodo (anno-mese-giorno) | 2013-09-01 - 2017-08-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
AALBORG UNIVERSITET
Organization address
address: FREDRIK BAJERS VEJ 5 contact info |
DK (AALBORG) | coordinator | 1˙026˙800.00 |
| 2 |
REGION NORDJYLLAND (NORTH DENMARK REGION)
Organization address
address: Niels Bohrs Vej 30 contact info |
DK (AALBORG) | participant | 588˙000.00 |
| 3 |
NOVOSENSE AB
Organization address
address: FORSKARBYN IDEON Scheelevagen 17 contact info |
SE (LUND) | participant | 587˙140.00 |
| 4 |
LUNDS UNIVERSITET
Organization address
address: Paradisgatan 5c contact info |
SE (LUND) | participant | 557˙160.00 |
| 5 |
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Organization address
address: BATIMENT CE 3316 STATION 1 contact info |
CH (LAUSANNE) | participant | 515˙200.00 |
| 6 |
ALBERT-LUDWIGS-UNIVERSITAET FREIBURG
Organization address
address: FAHNENBERGPLATZ contact info |
DE (FREIBURG) | participant | 486˙900.00 |
| 7 |
THE TRUSTEES OF INDIANA UNIVERSITY
Organization address
address: PO BOX 1847 contact info |
US (BLOOMINGTON) | participant | 464˙200.00 |
| 8 |
UNIVERSITE DE MONTPELLIER
Organization address
address: 163 RUE AUGUSTE BROUSSONNET contact info |
FR (MONTPELLIER) | participant | 426˙400.00 |
| 9 |
HOSPICES CANTONAUX CHUV
Organization address
address: Rue du Bugnon 21 contact info |
CH (LAUSANNE) | participant | 396˙400.00 |
| 10 |
UNIVERSITA CATTOLICA DEL SACRO CUORE
Organization address
address: Largo Agostino Gemelli 1 contact info |
IT (MILANO) | participant | 385˙600.00 |
| 11 |
OBELIA SARL
Organization address
address: CHEMIN DE SAINT BERNARD 2720 contact info |
FR (VALLAURIS) | participant | 349˙200.00 |
| 12 |
UNIVERSITAT AUTONOMA DE BARCELONA
Organization address
address: Campus UAB -BELLATERRA- s/n contact info |
ES (CERDANYOLA DEL VALLES) | participant | 199˙840.00 |
| 13 |
UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES
Organization address
address: PLACE EUGENE BATAILLON 2 contact info |
FR (MONTPELLIER) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Amputation of a limb may result from trauma or surgical intervention. The amputation traumatically alters the body image, but often leaves sensations that refer to the missing body part. In 50-80% amputees, neuropathic pain develops, also called phantom limb pain (PLP). Both peripheral and central nervous system factors have been implicated as determinants of PLP. Also, PLP may be triggered by physical (changes in the weather) and psychological factors (emotional stress). Recent evidence suggests that PLP may be intricately related to neuroplastic changes in the cortex, and that these changes may modulated by providing sensory input to the stump or amputation zone. However, the understanding of why PLP occurs is still poor, the basic research results have not been tested on a large scale in the clinic, and there are no fully effective, long-term treatments readily available on the market. We aim to challenge the status-quo of PLP therapy by offering technological solutions that will invasively or non-invasively induce natural, meaningful sensations to the amputee to restore the neuroplastic changes in the cortex and thereby control and alleviate PLP. We will assess the effect of cortical neuroplastic, psychological and cognitive components of pain and integrate the knowledge into clinical guidelines. The proposed work directly targets the HEALTH.2013.2.2.1-5 topic. The consortium will build solutions based on existing technologies emerging from previous EU funded research which are presently only available in experimental settings. We believe that implementation of proposed work will be the cornerstone needed to exploit, validate and translate the basic research results into clinical applications and provide long-term, patient-specific solutions to a large group of patients suffering from PLP. The work will assist to improve the quality of life for amputees suffering from phantom limb pain and is of high socio-economic relevance to the EU.'